Driving Growth, Innovation & Transformation with Oncology LLM Clinical Trial AI
Matching cancer patients to life-saving precision oncology clinical trials remains one of the most painfully slow bottlenecks in modern medical research. Over 80% of clinical trials experience enrollment delays, while fewer than 5% of adult cancer patients ever participate in trials, largely because critical eligibility data sits locked in unstructured clinical notes.
Standard commercial large language models fail in oncology due to extreme medical specificity. Extracting complex biomarker co-mutations (such as KRAS G12C or EGFR exon 20 insertions), previous lines of systemic therapy, and performance status requires deep domain adaptation and verifiable medical reasoning.
Blueflame Labs partners with cancer centers, biopharma sponsors, and oncology software innovators to engineer specialized clinical trial intelligence systems. We fine-tune medical foundation models on curated oncology corpora, implementing deterministic guardrails that guarantee flawless extraction accuracy.
Our data engineering teams develop high-throughput FHIR and HL7 data ingestion pipelines that continuously parse pathology reports, molecular sequencing panels, and physician consultation notes across comprehensive hospital EHR databases.
We construct patient-to-trial matching algorithms that evaluate hundreds of complex inclusion and exclusion criteria in seconds. Oncologists and clinical research coordinators receive ranked candidate cohorts with highlighted, verifiable evidence linked directly back to original clinical source documents.
Partnering with Blueflame Labs empowers cancer research institutions to accelerate trial accrual, democratize access to novel experimental therapies, and advance precision cancer care with state-of-the-art medical artificial intelligence.
